Next 10 |
home / stock / jnj / jnj articles
Editor’s note: We have updated the story with Kenvue’s statement in response to the report in paragraph 7 The World Health Organiz...
Drug shortages in the UK have more than doubled between 2020 and 2023, a recent study by the Nuffield Trust reveals. Brexit is cited as a significa...
The World Health Organization (WHO) is poised to issue a broader alert regarding contaminated children’s cough syrup produced by Johnson...
On Tuesday, Johnson & Johnson (NYSE:JNJ) reported first-quarter adjusted EPS of $2.71, up 12.4% year over year, beating the consensus...
Johnson & Johnson (NYSE: JNJ) reported better-than-expected first-quarter earnings on Tuesday. The company posted adjusted EPS of $2.71, up 12....
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates&n...
On Tuesday, Johnson & Johnson (NYSE:JNJ) reported first-quarter adjusted EPS of $2.71, up 12.4% year over year, beating the cons...
Earnings optimism may partly offset worries concerning rising bond yields and the volatile geopolitical situation in the Middle East, wit...
News, Short Squeeze, Breakout and More Instantly...
Editor’s note: We have updated the story with Kenvue’s statement in response to the report in paragraph 7 The World Health Organiz...
Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein’s 40 th Annual Strategic Decisions Conference (SDC) on Wednesday, May 29 th , at the New York Hilton Midtown, New York, NY. Joaquin Duato, Chairman and Chief Executive Officer will represent the Company in a sessio...
Drug shortages in the UK have more than doubled between 2020 and 2023, a recent study by the Nuffield Trust reveals. Brexit is cited as a significa...